XML 18 R4.htm IDEA: XBRL DOCUMENT v3.22.2.2
Condensed Consolidated Statements Of Operations - USD ($)
shares in Thousands, $ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Operating expenses:        
Research and development, net of grant reimbursement $ 18,526 $ 8,041 $ 50,380 $ 14,471
General and administrative 2,819 1,712 8,703 3,953
Total operating expenses 21,345 9,753 59,083 18,424
Operating loss (21,345) (9,753) (59,083) (18,424)
Interest income 878 15 1,223 35
Other income, net 210 176 748 176
Net loss $ (20,257) $ (9,562) $ (57,112) $ (18,213)
Net loss per share, basic and diluted $ (0.51) $ (0.24) $ (1.43) $ (0.46)
Shares used in computing net loss per share, basic and diluted 40,050 39,957 40,009 39,218